Web20 feb. 2024 · Ionis’ pipeline of antisense drugs is beginning to produce results – a separate alliance with Biogen resulted in development and approval of Spinraza (nusinersen), approved for spinal muscular... Web11 okt. 2024 · Ionis Pharmaceuticals has entered a deal worth up to $760m with Roche for further development of its antisense drug, IONIS-FB-L, to treat complement-mediated diseases.. IONIS-FB-L is designed using Ionis’ antisense technology platform. It uses the company’s ligand conjugated antisense (LICA) technology to decrease the generation of …
Antisense Pipeline Ionis - Ionis Pharmaceuticals, Inc.
WebThis page uses JavaScript. Your browser either doesn't support JavaScript or you have it turned off. To use this page please use a JavaScript enabled browser. WebIonis Pharmaceuticals is now hiring a Senior Research Associate - Gene Editing Core Research, Ion-Edit in Carlsbad, CA. View job listing details and apply now. ... For more information about Ionis and to apply for this position, please visit our website, www.ionispharma.com. Reference Requisition #IONIS002983. NO PHONE CALLS … northern allergy niagara falls
Ionis Job Board - recruiting.ultipro.com
WebIonis Job Board Company Location Job Category Schedule Reset Showing 50 of 63 opportunities By Newest Associate Director, Scientific Communications Today Job Category: Medical Affairs - Ionis Requisition Number: IONIS003053 Schedule: Full Time 2855 Gazelle Ct HQ USA Carlsbad, CA 92010, USA Click on the title to view position … WebPassword Center - Retrieve Forgotten Password Create new password Enter the customer number or a domain of your IONOS account and follow the next steps. Customer ID or domain Forgot your login details? Next Web2 aug. 2024 · CARLSBAD, Calif., Aug. 2, 2024 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today announced that pelacarsen, formerly known as AKCEA-APO(a)-L Rx, and licensed by Novartis (NYSE: NVS ... northern alliance financial